Diligence memo · auto-generated · as of July 2, 2026
NeuroReserve Inc.
NeuroReserve Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
NeuroReserve Inc. operates in Other Health Care, based in Las Vegas.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
NeuroReserve Inc. has raised $2.6M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.4M on 2022-08-31.
Most recent recorded round closed around 2025-01-24.
Valuation (modeled)modeled
Provath models NeuroReserve Inc. at approximately $2.4M (range $585K–$5.5M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.57× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 17 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 1.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 52% of Other Health Care peers (5377 compared).
Modeled value ranks above 10% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.